TELA Bio, Inc. (TELA) PT Lowered to $1 at Piper Sandler After '26 Rev Outlook Cut

March 25, 2026 9:39 AM

Piper Sandler analyst Matt O'Brien lowered the price target on TELA Bio, Inc. (NASDAQ: TELA) to $1.00 (from $1.25) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found